Skip to content

DASH Diet in Heart Failure Outpatients

DASH Diet in Heart Failure Pilot Study - Integration and Effectiveness of Medical Nutrition Therapy Counseling on DASH Diet in the Management of Heart Failure Patients in an Academic Outpatient Cardiology Clinic

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05117086
Acronym
DASH-HF
Enrollment
26
Registered
2021-11-11
Start date
2022-02-01
Completion date
2026-12-01
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Brief summary

The purpose of this study is to refine the classification of the effectiveness of the DASH diet for outpatient heart failure (HF) management, using behavioral, clinical, and laboratory correlative science approaches.

Detailed description

The overall objective of this pilot study is to refine the classification of the effectiveness of the DASH diet for outpatient HF management using behavioral, clinical, and laboratory correlative science approaches. The investigators will integrate the use and evaluation of DASH diet nutrition education in a clinical population using a pragmatic study approach. The investigators will assess dietary behavior change. The investigators will assess the medical effectiveness of the DASH diet to improve patient symptomology and clinical biomarkers. Exploratory investigations will involve metabolomics analyses of plasma samples for biomarker discovery of clinical phenotypes in HF patients, to characterize metabolic profiles related to dietary exposure.

Interventions

BEHAVIORALDASH diet

Nutrition education and counseling on DASH diet, behavioral and lifestyle modifications

Sponsors

University of California, Davis
Lead SponsorOTHER
American College of Cardiology
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Single arm pragmatic trial with pre- and post- assessments

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Heart Failure diagnosis * Guideline directed medical therapy optimization on stable regimen at least 30 days

Exclusion criteria

* BMI \< 18/5 kg/m squared * cardiac cachexia * end-stage renal disease or dialysis * acute inflammatory condition * uncontrolled arrhythmias or ischemia * status post heart transplant or implanted left ventricular assist device

Design outcomes

Primary

MeasureTime frameDescription
Dietary intakeDietary intake at baselineDietary intake assessed by nutrient analysis of food records
Diet scoreDietary intake at baselineDietary intake assessed by calculation of DASH diet score (Dietary Approaches to Stop Hypertension diet score). Minimum to Maximum values: 8-40 Higher scores mean better outcome and diet composition.
Blood PressureSystolic and diastolic Blood Pressure at baselineBlood Pressure assessed with systolic and diastolic pressure

Secondary

MeasureTime frameDescription
Heart Failure clinical markerproBNP at baselineproBNP will be assessed as a marker of severity of heart failure
Patient report of HF symptomsKCCQ at baselineKansas City Cardiomyopathy Questionnaire (KCCQ) will assess patient report of symptoms. Minimum to Maximum values: 0-100. Higher scores represent better outcome.
Patient report of eating habit self efficacyEating Habits at BaselineEating Habits Questionnaire will assess patient report of self efficacy for behavior change around DASH diet eating habits. Minimum to Maximum values:27-135. Higher value is better outcome.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORFrancene Steinberg, PhD

University of California, Davis

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 30, 2026